Evenity (romosozumab) is a prescription injectable medication used for the treatment of osteoporosis in postmenopausal women at high risk of fracture. It works by increasing bone formation and decreasing bone resorption, helping to improve bone strength and reduce the risk of fractures. Each pack contains 2 pre-filled syringes for convenient, monthly self-administration under medical supervision.

Key Features:

• Active ingredient: Romosozumab 105mg per pre-filled syringe.
• Designed for monthly subcutaneous injection.
• Increases bone mineral density and reduces fracture risk.
• Pre-filled syringes ensure accurate dosing and ease of use.
• Suitable for postmenopausal women with osteoporosis at high fracture risk.

Recommended Usage:

• Administer 1 pre-filled syringe once monthly via subcutaneous injection, as prescribed by a healthcare provider.
• Treatment duration and monitoring should follow physician guidance, including bone density and calcium/vitamin D status.
• Not intended for use in patients with hypocalcemia or cardiovascular risks without medical supervision.
• Patients should ensure adequate calcium and vitamin D intake during therapy.